Delivery Order SPE2DB22D6029-SPE2DB24FT9JV
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $5,004.74 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 20,000 units of Recothrom vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 24, 2023. No set-aside designation was used for this award issued against an indefinite-delivery contract held by Amerisourcebergen Drug Corp with the DLA. Through this...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide 20,000 units of Recothrom vials at a potential value of $8,341.20. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 12, 2023. No set-aside designation was applied to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- This is a $6,851.13 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of July 11, 2025. The contract is not set-aside and was awarded on July 10, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at one thousand sixty-eight dollars and twenty-one cents ($1,068.21) to supply five thousand (5,000) units of Thrombin-JMI vials to the Defense Logistics Agency Troop Support Medical (DLA). Performance will take place in Conshohocken, Pennsylvania over a one day period from September 13th through September 14th, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award is a Delivery Order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 20,000 unit vials of RECOTHROM, a medical product, with a ceiling value of $1,136.94 and a completion date of June 5, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- This federal contract award, identified as SPE2DB20D1100|SPE2DB25FY63R, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,775.28 Firm Fixed Price delivery order is for the supply of 20,000 units of RECOTHROM, a pharmaceutical product. The contract has an ultimate completion date of October 22, 2024 and was awarded on October 21, 2024. There is no set-aside designation for this contract....
- This federal contract award, valued at $3,322.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of the medication RECOTHROM, with a performance period through April 29, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FT9JVDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $5,464.97 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 20,000 units of Recothrom vials. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 30, 2023. No set-aside designation was applied to this award made under the DLA's open-market procurement procedures. As a prime contractor supporting DLA Troop Support Medical programs, Amerisourcebergen routinely provides pharmaceuticals and medical supplies for military treatment facilities on previous indefinite-delivery contracts. This order continues Amerisourcebergen's work supplying critical care products to DLA in support of the U.S. armed forces.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 11/29/23 |